Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review. - Wikidata - wikimedia - TriplyDB

Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.

Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.

http://www.wikidata.org/entity/Q38109663

about

Blood Biomarkers for Evaluation of Perinatal Encephalopathy Biomarkers of Brain Damage and Postoperative Cognitive Disorders in Orthopedic Patients: An Update The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment Diffuse axonal injury in brain trauma: insights from alterations in neurofilaments.Plasma soluble prion protein, a potential biomarker for sport-related concussions: a pilot study.Enhancement of Colorimetric Response of Enzymatic Reactions by Thermally Evaporated Plasmonic Thin Films: Application to Glial Fibrillary Acidic Protein.Networks of neuroinjury semantic predications to identify biomarkers for mild traumatic brain injury Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light Normothermic versus hypothermic cardiopulmonary bypass in children undergoing open heart surgery (thermic-2): study protocol for a randomized controlled trial.Neuron-Specific Enolase Is Correlated to Compromised Cerebral Metabolism in Patients Suffering from Acute Bacterial Meningitis; An Observational Cohort Study Kinetic modelling of serum S100b after traumatic brain injury.Microwave-accelerated bioassay technique for rapid and quantitative detection of biological and environmental samples.Therapeutics targeting the inflammasome after central nervous system injury.Current status of fluid biomarkers in mild traumatic brain injury Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury.Post-acute brain injury urinary signature: a new resource for molecular diagnostics.Addressing the needs of traumatic brain injury with clinical proteomics.Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury.Brain-Specific Serum Biomarkers Predict Neurological Morbidity in Diagnostically Diverse Pediatric Intensive Care Unit Patients.Glycyrrhizin improves p75NTR-associated sciatic nerve regeneration in a BALB/c mouse model.Biomarkers of Traumatic Brain Injury: Temporal Changes in Body Fluids Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome.Neuron-specific enolase correlates to laboratory markers of haemolysis in patients on long-term circulatory support.Functional resting-state fMRI connectivity correlates with serum levels of the S100B protein in the acute phase of traumatic brain injury.Serum neuron specific enolase is increased in pediatric acute encephalitis syndrome Phage display for identification of serum biomarkers of traumatic brain injury S100β as an early biomarker of excitotoxic damage in spinal cord organotypic cultures.The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis.Biomarkers, Genetics, and Epigenetic Studies to Explore the Neurocognitive Effects of Anesthesia in Children.Exploring effects of remote ischemic preconditioning in a pig model of hypothermic circulatory arrest.Prognostic value of neuron-specific enolase (NSE) for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review.Association of Salivary MicroRNA Changes With Prolonged Concussion Symptoms.Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms.Systematic Review of Human and Animal Studies Examining the Efficacy and Safety of N-Acetylcysteine (NAC) and N-Acetylcysteine Amide (NACA) in Traumatic Brain Injury: Impact on Neurofunctional Outcome and Biomarkers of Oxidative Stress and Inflammat

P2860

Q26741134-6134A6E2-FB32-461C-851D-34B8CF51118C Q26784577-C209D106-B72A-41B3-86D7-980F5F7AD50E Q26823924-273064D8-F5B6-46AF-BF69-EBBCD4095A2D Q30959630-C59B98F5-31F2-42D2-A2B1-AF6F3BBE365B Q34722271-34DA148D-4BF9-491C-AAFC-2B8B841C304A Q35039494-61C69254-A2AD-4C20-AA12-6FDB8FCC8487 Q35052998-A3235D52-411B-41C1-9452-6BFC73B37286 Q35620387-951EC20C-0D24-401D-BFCE-1EA46FA44D2C Q35681358-6A2363A4-A3E6-4827-8995-2346587940F8 Q35698008-F90586D3-56AE-4739-838B-3D2A6A81BAA5 Q35971525-83D0AA72-04FF-45E2-8B06-D8F3EFB58400 Q36055674-32066A02-0E11-4DD4-97EC-1B9F21EB538A Q36093532-6785D130-E935-41AA-8160-F0F743D60B6B Q36275988-EFB269EA-19AA-4226-8BBD-509FFDE64504 Q36424343-E39D0B38-C5DF-4CA9-BCD8-F33DB776AB86 Q36489525-9C566651-4C0B-4F72-BB5F-67A911179862 Q37061236-60F310C0-89AE-407E-8078-8BEE6A9A832F Q37240562-746CF6C0-B89E-400F-B072-D436B9C8D435 Q37590627-9895A80F-BC41-46B1-B700-05154F9E2065 Q37667700-25AFE957-2AB3-4A1C-9E8B-E2BF67156B13 Q37685775-888E3131-4E39-4D24-A95D-86C2466F5EC8 Q37724782-62B25096-B657-467E-A000-D7101C914C1B Q38644674-F6A8CC36-C762-4D7B-AAE4-FB3D9348BAB8 Q38685329-2F271F9B-2DE9-439A-8FDA-174E4AA84644 Q38726719-73BE8F52-CBF7-4AF4-A164-D517870CCF13 Q38825302-4020B434-6AEF-496C-8E58-2B1E451C037A Q39061827-05AECF92-B963-46D3-AB53-87058A618BF3 Q41072081-C6255639-D46B-474B-8BAB-CC420983ABFC Q41625125-BD3ADEC1-6185-47FB-B1CF-0A413AA7A026 Q42124482-F3FF71BD-274F-4179-A9DF-66ADF532D43F Q42376030-B516496F-ABB8-47BE-BDD3-8FA62914DF6C Q42382458-A8D93C93-49EC-4639-AEDB-51893774DCC3 Q44256923-DE3C3EE9-C9C8-4EAC-BF38-2DBF52470949 Q46156813-FD1DEC15-4A9D-4546-A15A-D66869FEBF44 Q46496633-00703FA9-9364-48CA-BEC7-7E4705524B99 Q47304323-B3E02CBB-CE17-4657-873B-4EA185B0E39D Q47441846-2FE456BE-1F85-418C-8E93-A1D52BF00BC0 Q47574720-FC488A8B-89E5-481C-9BB2-DA417E51DF6D Q47711481-8A7C3A3A-C6ED-4D20-87BA-B07698F82AC5 Q47827678-2BDC8CE1-FED4-4809-B135-EA78112E2DF4

P2860

Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.

http://www.wikidata.org/entity/Q38109663

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Biomarkers for the clinical di ...... n injury--a systematic review.

@en

type

label

Biomarkers for the clinical di ...... n injury--a systematic review.

@en

prefLabel

Biomarkers for the clinical di ...... n injury--a systematic review.

@en

P1433

Q38109663-E44955AB-1A30-4229-AAE0-6A631B09E6BA

P1476

Q38109663-44836956-E064-4530-BCCE-154555F1CFD2

P2093

Q38109663-2C41E145-88A3-42A2-9343-9E0F4B4A49AE

Q38109663-2DA4826B-B9BC-4984-862B-61DC8195FEF3

Q38109663-5E1297AD-C9F6-4159-ABF7-86583A3F73E9

Q38109663-69AA3CB9-D1A2-480C-ACE6-35AA95296D62

Q38109663-83315F1A-EE7A-4883-A7AD-096DE3F78E7D

Q38109663-96A3FEFA-33EB-4990-B6D0-52474D933A1C

P2860

Q38109663-094021FD-6393-4480-902C-11CE618E5827

Q38109663-0BE1314C-4B6E-48D5-84F3-BB5B2F8AB19B

Q38109663-0CF9CF41-9396-425C-8586-6AA9E9254606

Q38109663-0FEDEC54-C821-4249-8437-08B8BB85F5E1

Q38109663-1069FD54-9BA3-484C-8621-CF5FF47B44B7

Q38109663-187DF5A8-CF23-48DA-A2FB-262704D09941

Q38109663-1AAD2849-283D-4F46-881A-2013911B9D3E

Q38109663-1B8CFE1C-E694-479D-A470-7600FFDB6368

Q38109663-1E2932C3-C69B-4942-B1E7-E10A12D3B3FD

Q38109663-20A8F9CA-1706-4C8D-B1BB-E70376F264E6

P304

Q38109663-D139F612-F901-49F3-A6CA-9B8010BDE59B

P31

Q38109663-3999A58B-85D2-415B-9D3A-8470109537DB

P356

Q38109663-E1021D43-683D-4284-B299-F4472640415C

P433

Q38109663-CB35751B-C3E3-422F-BA66-D921C210B20C

P478

Q38109663-417D0D9E-6D51-46C0-BC4A-AE114261D9A6

P577

Q38109663-74C953A6-C7EA-4BC6-BED5-DFE3B9D77B89

P5875

Q38109663-099B52CD-A86A-49FA-934F-B82643BB18EC

P698

Q38109663-4D2F46D1-824F-4A37-A25F-8050FED8FEEF

P921

Q38109663-60457AD4-B648-47D9-86A3-5D89ED068426

Q38109663-65FB0BBB-6D7D-4F91-AEBA-C675F3658742

P932

Q38109663-BAB2D94D-05DE-4DB6-84BF-3A7587B96CBA

P356

P1433

CNS Neuroscience & Therapeutics

P1476

Biomarkers for the clinical di ...... n injury--a systematic review.

@en

P2093

Ishna Sharma

http://www.w3.org/2001/XMLSchema#string

Khadil Hosein

http://www.w3.org/2001/XMLSchema#string

Ross Bullock

http://www.w3.org/2001/XMLSchema#string

Shoji Yokobori

http://www.w3.org/2001/XMLSchema#string

Shyam Gajavelli

http://www.w3.org/2001/XMLSchema#string

Stephen Burks

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome

The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury

The S100 protein family: history, function, and expression

Multifunctional drugs for head injury

Proteasome inhibition arrests neurite outgrowth and causes "dying-back" degeneration in primary culture.

Diffuse axonal injury: novel insights into detection and treatment.

alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.

Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.

Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.

Human traumatic brain injury alters plasma microRNA levels.

P304

556-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CNS.12127

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236947366

http://www.w3.org/2001/XMLSchema#string

P698

23710877

http://www.w3.org/2001/XMLSchema#string

P921

traumatic brain injury

P932

6493562

http://www.w3.org/2001/XMLSchema#string